View Press Releases
-
Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat
-
Vaxess Announces Messenger Ribonucleic Acid (mRNA) Stability Results from Tests Assessing the Potential for Room-temperature Storage
Vaxess’s silk fibroin formulations protect mRNA lipid nanoparticles (LNPs) through drying, and maintain in vivo potency after storage at 37°C for two weeks
Apr 24, 2023
-
Cancer Support Community San Francisco Bay Area Launches Initiative to Provide Digital Cancer Care to Underserved Communities
Equiva Healthcare and Cancer Support Community (CSC) San Francisco Bay is announcing the activation of a new initiative to improve access to cancer support and education for those residing in under-connected Bay Area communities. The CSC Bay Area is the second CSC location to launch this program aimed at relieving the inequities and disproportional burden that cancer patients for certain population experience. Digital oncology support resources will be distributed using Equiva's Affordable Connectivity Program(ACP)-centric solution. CSC Bay Area will work with eligible households to enroll them in FCC’s ACP (which provides discounted broadband service) and distribute tablets to patients so they can access important cancer support services and resources.
Apr 23, 2023
-
BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development
BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.
Apr 12, 2023
-
Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme
Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency
Apr 10, 2023
-
Blue Spark Technologies to Present New Standard of Care for Temperature Monitoring at HIMSS 2023
Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the HIMSS Global Health Conference & Exhibition at McCormick Place Convention Center in Chicago April 17-21.
Apr 9, 2023
-
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences has recently launched comprehensive research solutions for studying cell death, particularly the apoptotic cell death.
Apr 9, 2023
-
STEMart Launches Bioburden and Sterility Testing for Medical Devices
STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.
Apr 9, 2023
-
Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection
Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera.
Apr 9, 2023
-
Main Ingredients of Cosmetics: Salicylic acid, AHA, Retinol, Avobenzone, Titanium dioxide
-
Introducing DroidGPT: AI that helps you select better open source software
Endor Labs, the startup helping development and security teams maximize the use of open source software (OSS), today launched in private beta Endor Labs DroidGPT – an AI that can help developers select better open source software.
Apr 6, 2023
-
BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global PartnersBOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.
Apr 6, 2023
-
CD ComputaBio Boosts Small Molecule Drug Development with Protein-Small Molecule Docking Service
-
High-Performance OLED and PLED Materials
-
Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials
Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging.
Apr 6, 2023
-
Bio-Rad iQ-Check Kits Receive AOAC INTERNATIONAL and AFNOR Approval for Use with the CFX Opus Deepwell Real-Time PCR System
-
MicroVal Approves Bio-Rad PCR Kit for Detection of STEC in Flour and Raw Dough
-
Bio-Rad’s QX600 Droplet Digital PCR System Advancing Measurable Residual Disease Research
Bio-Rad is accelerating measurable residual disease (MRD) research through more than a half dozen collaborations with institutions and companies leveraging its new QX600™ Droplet Digital™ PCR System, which boasts six color detection capable of quantifying 12 targets per well, a simple user workflow, and powerful data analysis. Maintaining Bio-Rad’s best-in-class ddPCR™ technology, this platform utilizes the same droplet generation and processing protocols as the QX200™ system, enabling thousands of current customers to adopt its advanced multiplexing capabilities easily.
Apr 5, 2023
-
MULTI-LEVEL BIO-SYNTHETIC CALIBRATION REFERENCE MATERIALS FOR URINE CHEMISTRIES AVAILABLE FROM VERICHEM
VERICHEM LABORATORIES now offers clinical laboratorians an extensive range of multi-level liquid stable biosynthetic clinical reference materials intended for use with urine chemistry assays.
Apr 5, 2023
-
InSysBio to release Immune Response Template 3.6.2 for QSP modeling
IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. IRT update focuses on usability and efficiency of search for information on the platform.
Apr 5, 2023